Difference between revisions of "Profiles"
Jump to navigation
Jump to search
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
Profiles published here have completed one of the [[QIBA Profile Stages]] of development and been approved by their [[Committees|Biomarker Committee]]. | Profiles published here have completed one of the [[QIBA Profile Stages]] of development and been approved by their [[Committees|Biomarker Committee]]. | ||
| − | |||
===[[QIBA_Profile_Stages#Stage_3:_Technically_Confirmed|Stage 3]]: Technically Confirmed=== | ===[[QIBA_Profile_Stages#Stage_3:_Technically_Confirmed|Stage 3]]: Technically Confirmed=== | ||
Revision as of 02:43, 21 May 2016
Profiles published here have completed one of the QIBA Profile Stages of development and been approved by their Biomarker Committee.
Stage 3: Technically Confirmed
Stage 2: Publicly Reviewed
Stage 1: Public Comment
- DCE-MRI Quantification 2011-12-13 (Public Comment ended Feb 2012)
- CT Volumetry for Advanced Disease 2011-07-08 (Public Comment ended Sept 2011)
See Also
- How to use QIBA Profiles
- QIBA Profile Template may provide additional understanding of the structure, rationale and content of a Profile (turn on Full Markup to see the guidance in the Word comments)
- Committees lists Biomarker Committees developing profiles which may link to DRAFT documents in progress for the next stage.
- Profile Conformance describes how sites and products claim conformance to a Profile.